ArticlePloS one2025
Barriers to early and effective overactive bladder management in male patients with lower urinary tract symptoms.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Transforming Urological Care With Artificial Intelligence Chatbots: From Digital Assistants to Clinical Partners.International neurourology journal · 2026Review
- Health Disparities and Overactive Bladder: Bridging the Gap.Current bladder dysfunction reports · 2026Review
- Correction: Barriers to early and effective overactive bladder management in male patients with lower urinary tract symptoms.PloS one · 2025Article
Corrections and comments
- Erratum issued
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Overactive bladder is underdiagnosed and undertreated in men as symptoms overlap with benign prostatic obstruction. This study identified barriers urologists encountered in effectively managing overactive bladder in men with lower urinary tract symptoms. 60 urologists recruited across Australia, Brazil, Colombia, Russia, South Korea and Thailand via convenience sampling participated in in-depth interviews. They were asked about their understanding and management of overactive bladder in men with lower urinary tract symptoms. Thematic analysis identified six themes: (1) overactive bladder diagnosis in men with lower urinary tract symptoms is complicated by the multi-factorial causes of storage symptoms; (2) patient-reported outcome tools are underutilized by urologists; (3) stigmatization and normalization of overactive bladder discourage men from seeking care; (4) challenges exist in tracking overactive bladder symptoms and in patient-urologist communication; (5) the underestimation of overactive bladder contributes to the non-urgency of its management; and (6) urologists may not fully appreciate the trade-offs between different overactive bladder treatments. Encouraging patient-reported outcome tool usage and differentiating the safety profiles of antimuscarinics and beta-3 agonists may facilitate timelier overactive bladder diagnosis and increase confidence in adding-on treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.